Harvard Bioscience, Inc. (HBIO)

NASDAQ: HBIO · Real-Time Price · USD

6.00

-0.19 (-3.07%)

At close: Jul 24, 2026, 4:00 PM EDT

6.03

+0.03 (0.50%)

After-hours: Jul 24, 2026, 7:34 PM EDT

Harvard Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	85.53	86.55	94.14	112.25	113.34	118.9
Revenue Growth (YoY)	-6.42%	-8.06%	-16.14%	-0.96%	-4.68%	16.46%
Cost of Revenue	35.56	36.64	39.37	46.18	52.52	51.25
Gross Profit	49.97	49.91	54.77	66.07	60.82	67.65
Selling, General & Admin	36.84	36.96	43.71	46.82	49.53	48.95
Depreciation & Amortization Expenses	3.69	4.03	5.26	5.53	6.12	5.84
Research & Development	8.83	8.83	10.41	11.76	12.33	10.8
Other Operating Expenses	0.7	48.68	1.61	0.07	-0.23	-
Total Operating Expenses	50.06	98.49	60.98	64.18	67.75	65.59
Operating Income	-0.09	-48.58	-6.21	1.89	-6.93	2.07
Interest Expense	-5.84	-4.92	-3.54	-3.59	-2.55	-1.54
Other Non-Operating Income (Expense)	-10.82	-12.7	-7.37	-5.31	-1.94	-2.87
Total Non-Operating Income (Expense)	-16.67	-17.61	-10.91	-8.9	-4.49	-4.41
Pretax Income	-16.75	-66.19	-17.12	-7.01	-11.43	-2.35
Provision for Income Taxes	-0.12	-0.69	0.74	0.86	0.34	0.15
Net Income	-16.64	-65.51	-17.86	-7.87	-11.76	-2.49
Net Income to Common	-9.78	-56.7	-12.41	-3.42	-9.52	-0.29
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	4	4	4	4	4	4
Shares Outstanding (Diluted)	4	4	4	4	4	4
Shares Change (YoY)	1.44%	1.96%	2.64%	2.43%	2.65%	4.41%
EPS (Basic)	-2.17	-12.80	-2.80	-0.80	-2.30	-0.10
EPS (Diluted)	-2.17	-12.80	-2.80	-0.80	-2.30	-0.10
EPS Growth	-	-	-	-	-	-
Free Cash Flow	1.91	5.47	-1.2	12.24	-0.44	0.07
Free Cash Flow Growth	273.78%	-	-	-	-	-99.18%
Free Cash Flow Per Share	0.43	1.23	-0.28	2.89	-0.11	0.02
Gross Margin	58.42%	57.67%	58.18%	58.86%	53.66%	56.90%
Operating Margin	-0.10%	-56.13%	-6.60%	1.69%	-6.12%	1.74%
Profit Margin	-19.45%	-75.69%	-18.97%	-7.01%	-10.38%	-2.10%
FCF Margin	2.23%	6.32%	-1.28%	10.90%	-0.39%	0.06%
EBITDA	5.55	-42.64	0.95	8.89	0.64	9.69
EBITDA Margin	6.49%	-49.26%	1.00%	7.92%	0.57%	8.15%
EBIT	-0.09	-48.58	-6.21	1.89	-6.93	2.07
EBIT Margin	-0.10%	-56.13%	-6.60%	1.69%	-6.12%	1.74%
Effective Tax Rate	0.69%	1.04%	-4.32%	-12.26%	-2.95%	-6.31%

SEC Filings: 10-K · 10-Q